These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 33764686)

  • 1. Effects of dosing frequency on the clinical efficacy of ampicillin/sulbactam in Japanese elderly patients with pneumonia: A single-center retrospective observational study.
    Suzuki T; Sugiyama E; Nozawa K; Tajima M; Takahashi K; Yoshii M; Suzuki H; Sato VH; Sato H
    Pharmacol Res Perspect; 2021 Apr; 9(2):e00746. PubMed ID: 33764686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of intravenous sulbactam/ampicillin 3 g 4 times daily in Japanese adults with moderate to severe community-acquired pneumonia: a multicenter, open-label, uncontrolled study.
    Kohno S; Tateda K; Mikamo H; Kadota J; Niki Y; Itamura R
    J Infect Chemother; 2015 Mar; 21(3):182-8. PubMed ID: 25533886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early switch therapy from intravenous sulbactam/ampicillin to oral garenoxacin in patients with community-acquired pneumonia: a multicenter, randomized study in Japan.
    Kohno S; Yanagihara K; Yamamoto Y; Tokimatsu I; Hiramatsu K; Higa F; Tateyama M; Fujita J; Kadota J
    J Infect Chemother; 2013 Dec; 19(6):1035-41. PubMed ID: 23695232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetics of ampicillin and sulbactam in patients with community-acquired pneumonia: evaluation of the impact of renal impairment.
    Soto E; Shoji S; Muto C; Tomono Y; Marshall S
    Br J Clin Pharmacol; 2014 Mar; 77(3):509-21. PubMed ID: 24102758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical efficacy of sulbactam/ampicillin in comparison with cefotiam in the treatment of elderly patients with pneumonia].
    Ishibashi T; Harada Y; Takamoto M; Ebihara M; Sugiyama M; Shimazu K; Iwanaga T; Kishikawa R; Makie T; Tsurutani H; Kisanuki K; Mitsuno T; Hirota N; Furuno T; Hiraoka T; Tsumori Y; Matsuura Y; Namba K; Oe T; Inuyama M; Chifu S; Fukunaga H; Ueno Y; Matsukizono K; Genka K
    Jpn J Antibiot; 1998 Dec; 51(12):746-58. PubMed ID: 10077773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ampicillin/sulbactam in elderly patients with community-acquired pneumonia.
    Majcher-Peszynska J; Loebermann M; Klammt S; Frimmel S; Mundkowski RG; Welte T; Reisinger EC; Drewelow B;
    Infection; 2014 Feb; 42(1):79-87. PubMed ID: 23904004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosing Optimization of Ampicillin-Sulbactam Based on Cystatin C in Elderly Patients with Pneumonia.
    Matsubara K; Matsumoto K; Yokoyama Y; Watanabe E; Enoki Y; Shigemi A; Ikawa K; Terazono H; Morikawa N; Ohshige T; Takeda Y
    Biol Pharm Bull; 2021; 44(5):732-736. PubMed ID: 33952829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacokinetic and bacteriological studies on sulbactam/ampicillin in the field of pediatrics].
    Sato Y; Ishikawa K; Iwata S; Akita H; Oikawa T; Sunakawa K
    Jpn J Antibiot; 1989 Mar; 42(3):579-93. PubMed ID: 2746843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical and pharmacokinetic studies on intravenous administration of sulbactam/ampicillin in pediatrics].
    Sato H; Narita A; Suzuki H; Nakazawa S; Matsumoto K; Nakanishi Y; Niino K; Nakazawa S
    Jpn J Antibiot; 1989 Mar; 42(3):623-38. PubMed ID: 2746846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetic, bacteriological and clinical studies on sulbactam/ampicillin in pediatric field].
    Nakao Y; Kimura H; Miura K; Miyajima Y; Ishikawa H; Hayakawa F; Kuno K
    Jpn J Antibiot; 1989 Mar; 42(3):639-50. PubMed ID: 2746847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical effect of ampicillin with beta-lactamase inhibitor (sulbactam/ampicillin) on community-acquired pneumonia in the elderly.
    Okimoto N; Kurihara T; Honda N; Asaoka N; Fujita K; Ohba H; Nakamura J
    J Infect Chemother; 2003 Jun; 9(2):183-6. PubMed ID: 12825120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacokinetic, bacteriological and clinical studies of sulbactam/ampicillin in pediatric patients].
    Motohiro T; Sakata Y; Oda K; Aramaki M; Tanaka K; Koga T; Shimada Y; Fujimoto T; Yamashita F; Sakamoto H
    Jpn J Antibiot; 1989 Mar; 42(3):773-90. PubMed ID: 2664252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of ceftriaxone plus macrolide and ampicillin/sulbactam plus macrolide in treatment for patients with community-acquired pneumonia without risk factors for aspiration: an open-label, quasi-randomized, controlled trial.
    Hamao N; Ito I; Konishi S; Tanabe N; Shirata M; Oi I; Tsukino M; Matsumoto H; Yasutomo Y; Kadowaki S; Hirai T
    BMC Pulm Med; 2020 Jun; 20(1):160. PubMed ID: 32503515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacokinetic, bacteriological and clinical evaluation of sulbactam/ampicillin in pediatrics].
    Hayashi M; Kida K; Matsuda H; Murase M
    Jpn J Antibiot; 1989 Mar; 42(3):743-53. PubMed ID: 2746854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on sulbactam/ampicillin in the field of pediatrics].
    Nakamura H; Miyazu M; Kasai K; Iwai N; Taneda Y
    Jpn J Antibiot; 1989 Mar; 42(3):662-74. PubMed ID: 2664250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical evaluation of sulbactam/ampicillin in children].
    Ito S; Mayumi M; Ito M; Mikawa H
    Jpn J Antibiot; 1989 Mar; 42(3):675-85. PubMed ID: 2664251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of Prophylactic Ampicillin-Sulbactam and Dosing Optimization in Patients Undergoing Cardiovascular Surgery with Cardiopulmonary Bypass.
    Yokoyama Y; Matsumoto K; Ikawa K; Watanabe E; Yamamoto H; Imoto Y; Morikawa N; Takeda Y
    Biol Pharm Bull; 2015; 38(11):1817-21. PubMed ID: 26521833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of ampicillin and sulbactam in pediatric patients.
    Nahata MC; Vashi VI; Swanson RN; Messig MA; Chung M
    Antimicrob Agents Chemother; 1999 May; 43(5):1225-9. PubMed ID: 10223940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sulbactam/ampicillin-induced pneumonitis].
    Miyashita N; Nakajima M; Kuroki M; Kawabata S; Hashiguchi K; Niki Y; Kawane H; Matsushima T
    Nihon Kokyuki Gakkai Zasshi; 1998 Aug; 36(8):684-9. PubMed ID: 9844387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of safety between high and low doses of sulbactam/ampicillin: A retrospective observational study in Japanese patients with pneumonia.
    Imanishi K; Nakakura I; Miyabe T; Sako R; Yamauchi K
    J Infect Chemother; 2020 Nov; 26(11):1152-1157. PubMed ID: 32622622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.